Prenatal education for congenital toxoplasmosis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Di Mario, Simona ^a   Basevi, Vittorio ^a   Gagliotti, Carlo ^b   Spettoli, Daniela ^a   Gori, Gianfranco ^a   D'Amico, Roberto ^c   Magrini, Nicola ^a  

^a AUSL Modena   (Italy)

^b Agenzia Sanitaria e Sociale Regionale dell'Emilia Romagna   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Female; Humans; Hygiene; Pregnancy; Pregnancy complications, parasitic *prevention control ; Prenatal care *methods ; Toxoplasmosis, congenital *prevention control

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY BLOOD LEVEL; AWARENESS; BLOOD SAMPLING; CLINICAL TRIAL; CONGENITAL TOXOPLASMOSIS; FOOD PROCESSING; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KNOWLEDGE; MATERNAL BEHAVIOR; PATIENT EDUCATION; PERSONAL HYGIENE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; QUESTIONNAIRE; REVIEW; RISK FACTOR; SEROCONVERSION; SYSTEMATIC REVIEW;

EID: 70249123064     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006171.pub2     Document Type: Review

References (41)

1. Carter AO, Gelmon SB, Wells GA, Toepell AP. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiology and Infection 1989;103:539-545
2. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy - an epidemiologic survey over 22 consecutive years. Journal of Perinatal Medicine 2004;32:211-214 (Pubitemid 38737524)
3. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. American Journal of Perinatology 1994;11:57-62. (Pubitemid 24046406)
4. Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstetrics & Gynaecology 1988;72:363-366 (Pubitemid 18206760)
5. Molé JR, Suárez D, Alonso F, Piquera G. This is what we did to prevent congenital toxoplasmosis in Manzanillo [Lo que hacemos para prevenir la toxoplasmosis congénita en Manzanillo]. Revista Cubana de Medicina General Integral 1992;8(4):330-332
6. Pawlowski ZS, Gromadecka-Sutkiewicz M, Skommer J, Paul M, Rokossowski H, Suchocka E, et al.Impact of health education on knowledge and prevention behavior for congenital tooplasmosis: the experience in Poznan, Poland. Health Education Research 2001;16(4):493-502. (Pubitemid 32769164)
7. Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: DOI: 10.1002/14651858.CD003252]
8. Allain JP, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by toxoplasma gondii in pregnant women from a regional population in the UK. Journal of Infection 1998;36:189-196 (Pubitemid 28165591)
9. Bader TJ, Macones GA, Asch DA. Prenatal screening for toxoplasmosis. Obstetrics & Gynecology 1997;90:457-464
10. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, et al.Risk factors for toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. American Journal of Obstetrics and Gynecology 2005;192:564-571 (Pubitemid 40214997)
11. Campbell MK, Elbourne DR, Altman DG for the CONSORT Group. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702-708
12. Chabbert E, Lachaud L, Crobu L, Bastien P. Comparison of two widely used PCR primer systems for detection of toxoplasma in amniotic fluid, blood, and tissues. Clinical Microbiology 2004;42:1719-1722 (Pubitemid 38500822)
13. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al.Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-147
14. Dunn D. Mother to child transmission of toxoplasmosis: risks estimates or clinical counselling. Lancet 1999;353:1829-1833 (Pubitemid 29251014)
15. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, et al.EpiInfo, Version 6: a word processing, database, and statistics programs for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
16. Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstetrics & Gynaecology 1988;72:363-366 (Pubitemid 18206760)
17. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. American Journal of Perinatology 1994;11:57-62. (Pubitemid 24046406)
18. Foulon W, Villena I, Stray-Pederson B, Decoster A, Lappalainen M, Pinon JM, et al.Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children sequelae at age 1 year. American Journal of Obstetrics and Gynecology 1999;180:410-415 (Pubitemid 29093877)
19. Foulon W, Pinon JM, Stray-Pederson B, Pollak A, Lappalainen M, Decoster A, et al.Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. American Journal of Obstetrics and Gynecology 1999;181:843-847 (Pubitemid 29503601)
20. Gilbert RE. Epidemiology of infection in pregnant women. In: Petersen E, Amboise-Thomas P editor(s). Congenital toxoplasmosis: scientific background, clinical management and control. Paris: Springer- Verlag France, 1999.
21. Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M, et al.Ecological comparison of the risks ofmother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiology and Infection 2001;127:113-120 (Pubitemid 32825646)
22. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. Journal of Medical Screening 2002;9:135-141 (Pubitemid 35205238)
23. Gilbert R, Gras L. European multicentre study on congenital toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG: an international journal of obstetrics and gynaecology 2003;110:112-120
24. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. Journal of Medical Screening 2007;14:8-13. (Pubitemid 46440359)
25. Hahn S, Puffer S, Torgerson DJ, Watson J. Methodological bias in cluster randomised trials. BMC Medical Research Methodology 2005;5:10. (Pubitemid 40594697)
26. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd..
27. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al.Classification system and case definitions of toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. European Journal of Clinical Microbiology and Infectious Diseases 1996;15:799-805.
28. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Petersen B, et al.Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 1999;353:1834-1837
29. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al.False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia toxo IgMtest. Journal of Clinical Microbiology 1997;35:174-178 (Pubitemid 26422649)
30. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965-1976
31. National Screening Committee Working Group. Antenatal and Newborn Screening for Toxoplasmosis. Report of the Working Group - October 2001. National Screening Committee, 2001.
32. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: DOI: 10.1002/14651858.CD001684]
33. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trialspublished in three general medical journals. BMJ 2003;327:785-789 (Pubitemid 37211172)
34. Reis R, Lösch R, Lago EG. Primary prevention of congenital toxoplsmosis [Prevenção primária da toxoplasmose congênita]. Acta Médica 1999;20:704-720
35. Rorman E, Stein Zamir C, Rilkis I, Ben-David H. Congenital toxoplasmosis - prenatal aspects of toxoplasma gondii infection. Reproductive Toxicology 2006;21(4):458-472
36. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Archives of Disease in Childhood 2006;91:661-665
37. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982-1999. Pediatric Infectious Disease Journal 2006;25:123-128
38. Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: ameta-analysis of individual patients' data. Lancet 2007;369:115-122 (Pubitemid 46073130)
39. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, et al.Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG: an international journal of obstetrics and gynaecology 2005;112:567-574 (Pubitemid 40675790)
40. Torgerson DJ. Contamination in trials: is cluster randomisation the answer?. BMJ 2001;322:355-357
41. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767-774 (Pubitemid 11250438)